U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06804122) titled 'Exercise-based Rehabilitation in Patients with Pulmonary Artery Disease' on Jan. 27.
Brief Summary: Pulmonary arterial hypertension (PAH) is a rare and severe disease characterized by elevation of pulmonary artery pressure (PAP) and increased pulmonary vascular resistance (PVR) due to the narrowing of small pulmonary arteries. The European Society of Cardiology (ESC) and the European Respiratory Society (ERS) recommend supervised exercise-based rehabilitation as part of the treatment of PAH patients alongside optimal medical therapy (Level of evidence A, Class of recommendation I).
Studies on exercise-based rehabilitation for PAH pa...